A fascinating court case in Australia has been playing out around some people who had heart attacks after taking the Merck drug Vioxx. This medication turned out to increase the risk of heart attacks in people taking it, although that finding was arguably buried in their research, and Merck has paid out more than £2bn to 44,000 people in America – however, they deny any fault……Read more
Providing the busy pharmaceutical executive with insight into industry trends that will affect their business, as well as the industry in its entirety.
The current spate of mergers and acquisitions in the global pharma
space has mostly been driven by the need to deal with receding product
lines and patent expiries.